GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stimcell Energetics Inc (OTCPK:STME) » Definitions » Cyclically Adjusted PB Ratio

STME (Stimcell Energetics) Cyclically Adjusted PB Ratio : (As of May. 13, 2025)


View and export this data going back to 2013. Start your Free Trial

What is Stimcell Energetics Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Stimcell Energetics Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Stimcell Energetics's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stimcell Energetics Cyclically Adjusted PB Ratio Chart

Stimcell Energetics Annual Data
Trend May15 May16 May17 May18 May19 May20 May21 May22 May23 May24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Stimcell Energetics Quarterly Data
May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Stimcell Energetics's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Stimcell Energetics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stimcell Energetics's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stimcell Energetics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Stimcell Energetics's Cyclically Adjusted PB Ratio falls into.


;
;

Stimcell Energetics Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Stimcell Energetics's Cyclically Adjusted Book per Share for the quarter that ended in Feb. 2025 is calculated as:

For example, Stimcell Energetics's adjusted Book Value per Share data for the three months ended in Feb. 2025 was:

Adj_Book=Book Value per Share/CPI of Feb. 2025 (Change)*Current CPI (Feb. 2025)
=-0.054/128.7859*128.7859
=-0.054

Current CPI (Feb. 2025) = 128.7859.

Stimcell Energetics Quarterly Data

Book Value per Share CPI Adj_Book
201505 -0.331 100.263 -0.425
201508 -0.435 100.579 -0.557
201511 -0.516 100.421 -0.662
201602 -0.581 100.421 -0.745
201605 -0.684 101.765 -0.866
201608 -0.794 101.686 -1.006
201611 -0.187 101.607 -0.237
201702 -0.288 102.476 -0.362
201705 -0.436 103.108 -0.545
201708 -0.384 103.108 -0.480
201711 -0.206 103.740 -0.256
201802 -0.284 104.688 -0.349
201805 -0.363 105.399 -0.444
201808 -0.446 106.031 -0.542
201811 -0.487 105.478 -0.595
201902 -0.555 106.268 -0.673
201905 -0.601 107.927 -0.717
201908 -0.362 108.085 -0.431
201911 -0.395 107.769 -0.472
202002 -0.394 108.559 -0.467
202005 -0.408 107.532 -0.489
202008 -0.376 108.243 -0.447
202011 -0.425 108.796 -0.503
202102 -0.477 109.745 -0.560
202105 -0.381 111.404 -0.440
202108 -0.370 112.668 -0.423
202111 -0.407 113.932 -0.460
202202 -0.439 115.986 -0.487
202205 -0.479 120.016 -0.514
202208 -0.502 120.569 -0.536
202211 -0.524 121.675 -0.555
202302 -0.549 122.070 -0.579
202305 -0.569 124.045 -0.591
202308 -0.589 125.389 -0.605
202311 -0.602 125.468 -0.618
202402 -0.036 125.468 -0.037
202405 -0.042 127.601 -0.042
202408 -0.046 127.838 -0.046
202411 -0.050 127.838 -0.050
202502 -0.054 128.786 -0.054

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Stimcell Energetics  (OTCPK:STME) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Stimcell Energetics Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Stimcell Energetics's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Stimcell Energetics Business Description

Traded in Other Exchanges
N/A
Address
1130 Pender Street, West, Suite 820, Vancouver, BC, CAN, V6E 4A4
Stimcell Energetics Inc is a biotech company focused on the discovery, development and commercialization of therapeutic and non-therapeutic products that enhance cellular function, promote general wellness and alleviate health complications including, but not limited to: aging, diabetes, high blood pressure, neuropathy and kidney function. The Company's main focus is on continued research and development of its eBalance Technology and its eBalance Home System.
Executives
Richard Jeffs 10 percent owner FLAT 7, 6 ENNISMORE GARDENS, LONDON X0 SW7 1NL
Dwayne Yaretz director, officer: Chief Executive Officer SUITE 1050 WEST PENDER STREET SUITE 2250, VANCOUVER A1 V6E 3S7
Bradley S Hargreaves 10 percent owner 904-1616 BAYSHORE DR, VANCOUVER A1 V6G3L1
Frank Mcenulty director, officer: CEO, CFO, Treas., Sec 4182 N. VIKING WAY, SUITE 216, LONG BEACH CA 90808-1475
Joao Dacosta director, officer: COO #810 - 789 WEST PENDER STREET, VANCOUVER A1 V6C 1H2
George Adams director 7535 CONSERVATION ROAD, GUELPH A6 N1H6J1
Terrance George Owen director, officer: CEO 635 FOURTH LINE (UNIT 1), OAKVILLE A6 L6L 5BO
John David Sanderson officer: Chief Medical Officer 9 ISLANDVIEW, IRVINE CA 92604
Yanika S Silina officer: CFO, Treasurer and Secretary 789 WEST PENDER STREET, UNIT 810, VANCOUVER A1 V6C 1H2
Jean M Arnett 10 percent owner 121 - 3989 HENNING DRIVE, BURNABY A1 V5C 6P8
Ean Kremer director, officer: Chief Technology Officer C/O PLANDEL RESOURCES, INC., 4575 DEAN MARTIN DRIVE, STE. 2206, LAS VEGAS NV 89103